Merck Q3 Earnings Preview: Analysts project ~50% EPS growth as Keytruda remains in focus (MRK:NYSE)

Core Insights - Merck is scheduled to report its third-quarter earnings on October 30, before market opens [3] - Consensus estimates predict earnings per share of $2.35, representing a year-over-year increase of 49.7% [3] - Revenue is expected to reach $16.98 billion, indicating a 1.7% increase compared to the same period last year [3]